Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

NCT00951405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A With Inhibitors
Haemophilia B With Inhibitors

Interventions

DRUG: activated recombinant human factor VII, long acting
DRUG: activated recombinant human factor VII, long acting
DRUG: activated recombinant human factor VII, long acting

Sponsor

Novo Nordisk A/S